SARS-CoV-2 infection during pregnancy
Authors:
- Ulrich PecksUPUlrich Pecks
- Nadine MandNMNadine Mand
- Thomas KolbenTKThomas Kolben
- Mario RüdigerMRMario Rüdiger
- Peter OppeltPOPeter Oppelt
- Janine ZöllkauJZJanine Zöllkau
- Astrid DempfleADAstrid Dempfle
- 5 September 2022
- journal article
- research article
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 119 (35-36) , 588-+
Abstract
Using data from the German CRONOS registry, we assessed the risk of a complicated course of COVID-19 in women with a SARS-CoV-2-infection during pregnancy, with particular consideration of gestational age, vaccination status, and pandemic dynamics. Data acquired in two separate periods (March 2020 to August 2021; January to June 2022) for CRONOS, a prospective, hospital-based observational study (DRKS00021208), were studied with logistic regression models. Odds ratios comparing 32 with 22 weeks of gestation were calculated for relevant COVID-19-specific events occurring within 4 weeks of a positive test result. Data from 3481 women were evaluated. The risk of all of the defined COVID-19-specific events was low among women who became ill with COVID-19 during the first trimester and rose with increasing gestational age into the early third trimester. For example, the odds ratio for hospitalization because of a COVID-19 infection, comparing 32 versus 22 weeks of gestation, was 1.4 (95% confidence interval [1.2; 1.7]). This risk was lower in the second period of data acquisition than in the first (OR 0.66; 95% CI [0.50; 0.88]), and it was even lower if the pregnant patient had been vaccinated against COVID-19 (OR 0.27; 95% CI [0.18; 0.41]). These findings can serve as a basis for counseling about prophylactic or therapeutic measures, such as the administration of monoclonal antibodies. They underscore the efficacy of vaccination for pregnant women even during the omicron phase of the pandemic.Keywords
This publication has 19 references indexed in Scilit:
- Pregnant and breastfeeding women’s attitudes and fears regarding the COVID-19 vaccinationArchives of Gynecology and Obstetrics, 2021
- Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancyNature Medicine, 2021
- The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysisCanadian Medical Association Journal, 2021
- Pregnancy and SARS-CoV-2 Infection in Germany—the CRONOS RegistryDeutsches Ärzteblatt international, 2020
- Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysisBMJ, 2020
- Aktualisierte Empfehlungen zu SARS-CoV-2/COVID-19 und Schwangerschaft, Geburt und WochenbettZeitschrift für Geburtshilfe und Neonatologie, 2020
- Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Regression Modeling Strategies2015
- THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIALBiometrika, 1934